Cited 0 times in
GS-003: Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.